🇺🇸

US SEC Filing Intelligence

· daily

Global High-Priority Regulatory Events — August 27, 2026

The August 27, 2026, filing set is dominated by a wave of corporate actions, including a high volume of SPAC business combinations, delistings, and insolvency proceedings, creating a bifurcated market environment. A clear theme is the aggressive push into high-growth sectors like quantum computing (Bleichroeder/Pasqal), electric vehicles (Hero MotoCorp/Ather), and space technology (Black Spade/Astrum), all backed by substantial capital commitments. Conversely, a significant number of companies are facing existential threats, with multiple Nasdaq delisting notices (Lottery.com, Rein Therapeutics, SOBR Safe) and formal delistings (Forte Biosciences, Leggett & Platt) signaling a purge of non-compliant or acquired entities. The data reveals a stark contrast between capital-rich entities executing transformative deals and distressed companies struggling with regulatory compliance and financial viability. Key period-over-period trends include strong revenue growth in the EV and renewable energy sectors (Ather Energy at 44% CAGR, Florens Fresh at 95% YoY), contrasted with declining revenues at Radiance KA Sunshine Seven. Insider activity is limited but includes a notable debt forgiveness by Jupiter Neurosciences executives, signaling strong insider alignment. The forward-looking landscape is packed with catalyst-rich events, including critical NCLT hearings for Indian insolvencies and shareholder meetings for major amalgamations, providing a clear calendar for event-driven strategies.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 27, 2026

Today's filings reveal a market dominated by corporate restructuring, capital allocation shifts, and mixed earnings results. A notable theme is the significant insider selling at Sea Ltd across multiple C-suite executives, totaling over $5.4 million, which raises concerns about management conviction despite the company's strong market position. On the earnings front, a divergence is clear: Salesforce and CrowdStrike show strong revenue growth and improving profitability, while HP Inc. and Hormel Foods face margin compression from one-time charges and restructuring costs. The capital markets are active, with several companies (Eightco, Healthy Choice Wellness, Serina Therapeutics) pursuing dilutive financing strategies, while KKR faces a $250 million antitrust penalty. A major corporate control event is unfolding at Nexa Resources, with its controlling shareholder agreeing to sell its stake to Boliden. Overall, the data suggests a cautious market environment where companies are aggressively managing balance sheets and insiders are taking profits, while investors should focus on quality names with clear growth trajectories and prudent capital allocation.

23 high priority 27 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 27, 2026

The six filings from the S&P 500 Consumer Discretionary sector reveal a bifurcated landscape. Home improvement retailers Lowe's and Home Depot show divergent trends: Lowe's posted strong 8.3% YoY revenue growth but flat earnings, while Home Depot saw an insider sale from a senior executive. Beauty retailer Ulta Beauty delivered solid 8.9% YoY sales growth and raised guidance, yet its cash position collapsed 63% due to aggressive share buybacks, signaling a capital allocation shift. Insider activity is mixed: DoorDash's President sold ~$4.8M under a 10b5-1 plan (negative signal), while Amazon's Executive Chair Bezos made large gifts (neutral). The sector is seeing margin stabilization (Ulta, Lowe's) but cash flow pressures from reinvestment and shareholder returns. Key portfolio-level themes include a divergence in capital allocation (buybacks vs. reinvestment) and insider selling at elevated levels.

5 high priority 1 medium 6 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 27, 2026

All four S&P 500 Healthcare filings from August 27, 2026, reveal a pronounced insider selling wave, with three senior executives and a director liquidating significant equity positions totaling ~$30 million. Abbott Laboratories' Chairman & CEO Robert Ford leads the divestiture, netting ~$25.3 million after exercising options, a high-materiality signal (9/10). Gilead Sciences' Director Anthony Welters sold ~$1.02 million under a 10b5-1 plan, while Center Corporation's General Counsel sold ~$3.78 million. Beeton Dickinson's smaller $31K sale by an EVP appears routine. This coordinated de-risking across large-cap healthcare suggests management teams may be locking in gains near perceived valuation peaks or ahead of sector headwinds. No period-over-period financial trends, forward guidance, capital allocation shifts, or M&A activity were reported, so the dominant theme is equity sentiment divergence between insiders and public markets. The sector faces an insider confidence test, as these transactions occur without offsetting bullish signals like buybacks or raised guidance.

4 high priority 4 total filings
· daily

US Earnings Financial Results SEC Filings — August 27, 2026

The 35 filings reveal a bifurcated market where consumer-facing and enterprise tech companies show robust top-line growth, but profitability is under pressure from rising costs, restructuring charges, and aggressive capital allocation. A clear theme is the 'profitless growth' or 'growth at a cost' pattern, where several companies (Lucky Strike, HP Inc, Malibu Boats) reported revenue increases alongside net income declines. Conversely, companies like Dollar Tree, Burlington Stores, and CrowdStrike demonstrate strong operational leverage with significant margin expansion and earnings growth. Insider activity is sparse in the data, but capital allocation is a dominant story, with massive share repurchase programs at Salesforce ($27.4B in H1), Workday ($2.9B), and Ulta Beauty ($793M) signaling management confidence but also straining balance sheets. The SPAC and pre-revenue entities (AMR Resources, Alchemy Investments) continue to burn cash with no clear path to profitability, representing high-risk vehicles. Sector-wise, discount retailers (Dollar Tree, Dollar General) and aerospace/defense (HEICO) are outperforming, while legacy retail (Cato Corp) and food (Hormel) face headwinds. The most critical development is the aggressive buyback activity, which is reducing share counts and boosting EPS but depleting cash reserves and increasing leverage, a trend that warrants close monitoring for sustainability.

35 high priority 35 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 27, 2026

The five filings in this digest reveal a mixed landscape of corporate governance and strategic moves, with a notable shift toward high-risk/high-reward transactions and shareholder value considerations. The most significant development is Armada Acquisition Corp. II's proposed business combination to form a publicly traded XRP treasury company, a novel and highly speculative SPAC deal that could set a precedent for crypto treasury structures but carries substantial redemption risk. Belpointe PREP, LLC's proposed $250 million public offering signals a capital-intensive growth strategy in the real estate/prep sector, while U.S. Gold Corp. and Singularity Future Technology Ltd. show more routine governance with no major period-over-period trends or insider activity reported. VALIC Co I's joint special meeting for the Corebridge/Equitable merger highlights ongoing consolidation in the financial services industry, with Nippon Life's involvement adding a cross-border dimension. Overall, the filings show a bifurcation between stable, governance-focused companies and those pursuing transformative, high-stakes transactions.

5 high priority 5 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 27, 2026

The IPO pipeline for August 27, 2026, reveals two distinct but high-risk capital markets transactions: a dilutive equity line of credit (ELOC) resale filing by Reliance Global Group and a SPAC business combination filing by CADV Ventures. Both filings signal significant uncertainty and potential volatility for existing shareholders. Reliance Global Group's S-1 highlights a precarious Nasdaq listing status, with the company having just regained compliance via a 1-for-40 reverse split but now facing a new $5.0 million market value requirement. The ELOC structure, with up to $50 million in potential share sales, poses a substantial dilution risk. CADV Ventures' S-4 for a SPAC merger introduces binary risk from public shareholder redemptions, with pro forma scenarios ranging from 0% to 100% redemption, directly impacting post-closing cash and share counts. No period-over-period comparisons, insider trading, or forward-looking guidance were available in the enriched data for either filing, limiting trend analysis but underscoring the early-stage and speculative nature of these transactions.

2 high priority 2 total filings
· daily

US SEC Trading Suspension Halt Orders — August 27, 2026

The four filings paint a stark picture of distress among small-cap micro-cap companies on the Nasdaq, with three receiving deficiency or delisting notices and only one regaining compliance. The primary theme is a wave of non-compliance driven by delayed periodic filings (Lottery.com) and sustained low stock prices (Rein Therapeutics, SOBR Safe). A notable pattern is the heavy reliance on reverse stock splits as a last-resort compliance tool, with SOBR Safe's cumulative 1-for-1100 split rendering it ineligible for standard grace periods, while Onfolio's recent split successfully restored its bid price. Insider activity is limited but negative, with a director resignation at SOBR Safe. The capital allocation picture is one of survival, not growth, with no dividends or buybacks. The most critical development is SOBR Safe's existential deadline of September 15, 2026, to complete a business combination or face delisting, making it a high-risk event to watch.

4 high priority 4 total filings
· daily

US Executive Officer Management Changes SEC — August 27, 2026

This digest of 35 executive and director change filings reveals a period of significant leadership transition across US equities, with notable CFO movements at Rivian, GE Vernova, and Affirm creating a high-profile talent reshuffle. The data shows a clear bifurcation: companies with strong operational performance, like Rubrik (subscription ARR +33% YoY) and Affirm (first GAAP profitable quarter, revenue +47% YoY), are experiencing leadership departures from a position of strength, while others like QVC (post-bankruptcy restructuring) and Kuber Resources (accounting scandal) face departures amid distress. Period-over-period comparisons highlight that 3 of 5 companies reporting earnings in this batch (Build-A-Bear, Gap Inc., Affirm) showed mixed results with revenue declines or slowdowns offset by margin improvements or strategic gains. Insider activity is limited but notable: the Icahn Group's exit from JetBlue's board signals reduced activist pressure, while the CFO moves at Rivian and GE Vernova create a direct talent pipeline. Forward-looking statements indicate cautious guidance from Build-A-Bear (lowered FY outlook) and Gap (reduced sales forecast), contrasting with Rubrik's raised guidance. The overall theme is one of strategic repositioning, with companies either strengthening leadership for growth or managing transitions amid operational challenges.

35 high priority 35 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 27, 2026

The filing set is dominated by finance-leadership turnover, planned succession, and board contraction rather than activist-driven governance disruption. At least eight CFO or principal-finance changes are disclosed, including Rivian's planned CFO departure, Affirm's CFO resignation and interim replacement, Outlook Therapeutics' CFO succession, Satellogic's interim CFO appointment, Envoy Medical's permanent appointment of its interim CFO, Karman's planned CFO transition, Terra Innovatum's CFO appointment, and Kuber Resources' highly contentious CFO departure. Several changes appear orderly and potentially constructive, including GE Vernova's internally coordinated succession with Claire McDonough joining months before becoming CFO and Elastic's nomination of former Microsoft Developer Division President Julia Liuson to support its AI strategy. Conversely, Kuber Resources presents the most severe governance and reporting risk because its former CFO alleged restricted access to books and records, the company has delayed its annual report, and management has not established whether prior financial statements remain reliable. Board sizes are being reduced at Dine Brands, Life Time, Outlook Therapeutics, JetBlue, and Lam Research, while QVC is eliminating senior operating roles following bankruptcy. No insider purchases, sales, pledges, or other conviction signals were provided in the enriched data; investors should therefore avoid inferring insider sentiment from these filings. The most actionable dates are September 1-30 CFO transitions, September 3 Dine Brands' board reduction, September 4 QVC leadership departures, October 2026 Elastic's shareholder vote, October 30 Rivian's CFO departure, November 2 Lam Research retirements, and January-April 2027 GE Vernova's CFO handoff.

35 high priority 35 total filings
· daily

USA Insider Trading Pulse — August 27, 2026

The August 27, 2026 insider trading pulse reveals a pronounced bearish tilt, with 15 sell transactions from C-suite executives at high-growth and established firms, including Tempus AI, Sea Ltd, DoorDash, and Twist Bioscience, many executed under 10b5-1 plans. The most concentrated selling occurred at Sea Ltd, where the CEO, COO, and two other senior leaders collectively sold over $5 million in shares, signaling potential caution despite the company's growth narrative. On the positive side, Comscore's CEO made a $105,000 open-market purchase, a rare bullish signal for a struggling firm, while Horizon Kinetics made token buys in Texas Pacific Land and RENN Fund. The data shows a clear divergence: insiders at cash-flow-rich companies like Church & Dwight and Service Corp International are monetizing options or reducing large positions, while insiders at smaller, distressed firms are buying. No forward-looking guidance changes or major capital allocation shifts were detected in this batch, but the sheer volume of insider selling at key names warrants a defensive posture in growth and tech sectors.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 27, 2026

This digest covers 11 SEC filings related to US M&A and takeover activity, predominantly SPAC-related business combinations and asset sales. The most significant development is the Armada Acquisition Corp. II proposal to form a publicly traded XRP treasury company with over $1 billion in private placement commitments, a high-risk, high-reward transaction that could reshape digital asset exposure for public markets. The Pasqal business combination via Bleichroeder Acquisition Corp. II brings a leading quantum computing firm to Nasdaq with $360M in cash, while Black Spade Acquisition III's $1B deal with Astrum Space highlights continued SPAC interest in space tech. A notable trend is the acceleration of SPAC IPO activity (Southern Cross Acquisition II Corp. and OceanLight Acquisition Corp.), suggesting renewed market appetite for blank-check vehicles. On the corporate side, Ashford Hospitality Trust's asset sale demonstrates ongoing portfolio rationalization in the hospitality sector, while ABVC BioPharma's spin-off of BioKey represents a strategic separation. Insider activity is limited across filings, but capital allocation patterns show a focus on funding growth through SPAC structures rather than traditional debt or equity offerings. The overall sentiment is cautiously optimistic, with several high-materiality transactions carrying execution and regulatory risks.

11 high priority 11 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 27, 2026

This overnight filing cycle reveals a market bifurcated between strong operational performance in large-cap tech and consumer staples, and severe distress in micro-cap and pre-revenue companies. Salesforce, Okta, and HP Inc. posted double-digit revenue growth and significant margin improvements, while CrowdStrike achieved a major profitability milestone. However, this is contrasted by a wave of insider selling across sectors—including Lazard, Delek US, and Faraday Future—and alarming financial deterioration at Eightco Holdings, M2i Global, and Standard Nuclear. A notable regulatory development is KKR's $250M antitrust settlement, while the SPAC space sees continued de-SPAC activity with Plum III and Inflection Point. The most actionable themes are the divergence in capital allocation (aggressive buybacks at Salesforce vs. dilutive financing at Serina) and the concentration risk emerging in the digital asset treasury strategy at Eightco.

39 high priority 11 medium 50 total filings
· daily

New Federal Contractors — August 26, 2026

This digest covers four civilian agency contracts totaling $502.6 million, with zero defense-related awards, underscoring a non-DOD procurement focus. The dominant theme is stable, recurring revenue from long-duration, low-risk pricing structures (cost-plus and firm-fixed-price) across health IT, air traffic management, and workforce training. The highest-conviction signal is Leidos’ $127 million FAA contract for the Enterprise Information Display System, which reinforces its competitive moat in federal IT infrastructure with a mature, low-risk cost-plus structure. A key risk is the expiration of Harvard Pilgrim Health Care’s $110.7 million FDA Sentinel contract in December 2024, which could trigger a competitive re-compete and disrupt stable revenue.

4 total filings
· daily

Significant Contract Modifications ($10M+) — August 26, 2026

This digest covers four civilian agency contracts totaling $502.6 million from the Departments of Labor, Transportation, and Health and Human Services, with zero defense-related awards — a notable divergence from typical government spending patterns. The highest-conviction signal is Leidos’ $127 million base cost-plus-fixed-fee FAA contract for the Enterprise Information Display System (E-IDS), which signals stable, recurring IT infrastructure revenue through 2034. However, three of the four contracts are from 2017-2019, raising execution maturity and renewal risk: ADAMS AND ASSOCIATES ($158M, DOL) and Harvard Pilgrim Health Care ($110.7M, HHS/FDA) both have over 70% of value already outlayed, while Management & Training Corporation’s $106.9M DOL Job Corps contract expired October 2022 with no extension evidence. Key risk: no bullish/bearish signals were identified in the source data, and the average signal strength is moderate (5.5/10), limiting actionable conviction.

4 total filings
· daily

Contract Deobligations Alert — August 26, 2026

This digest covers $502.6 million in contract obligations from August 26, 2026, all from civilian agencies with zero defense exposure. The largest award is a $158 million Department of Labor contract to Adams and Associates for technical training, signaling sustained federal investment in workforce development. The highest-conviction signal is Leidos' $127 million FAA contract for the Enterprise Information Display System, a cost-plus-fixed-fee award that provides stable, long-duration revenue through 2034 but caps margin upside. A key risk is the maturity of several contracts: Leidos' base value is 96% outlayed, and Management & Training Corporation's Job Corps contract expires in October 2022 with no extensions exercised, indicating potential revenue cliffs. The digest shows a civilian-heavy, low-defense exposure period with neutral signals across all awards.

4 total filings
· daily

Contract Option Exercises — August 26, 2026

This digest covers $502.6 million in civilian contract obligations from August 26, 2026, with zero defense-related awards. The dominant theme is stable, long-duration federal services contracts across civilian agencies, led by the Department of Labor ($264.9M combined), Department of Transportation ($127M), and Department of Health and Human Services ($110.7M). The highest-conviction signal is Leidos' $127 million Cost Plus Fixed Fee contract with the FAA for the Enterprise Information Display System, offering low-risk, recurring revenue through 2034. A key risk is the Management & Training Corporation's Job Corps contract expiring October 2022 without exercised options, signaling potential budget contraction in workforce training programs. All four contracts carry neutral signals, reflecting mature, non-transformational awards with limited equity upside catalysts.

4 total filings
· daily

Federal IT & Cybersecurity Contracts — August 26, 2026

The digest covers $237.7 million in total obligations across two civilian agency contracts, with zero defense-related awards. The dominant theme is stable, long-duration federal IT and health data infrastructure, led by Leidos’ $127 million cost-plus contract with the FAA for the Enterprise Information Display System through 2034, signaling recurring revenue but capped margin upside. Harvard Pilgrim Health Care’s $110.7 million firm-fixed-price FDA Sentinel Initiative contract reinforces demand for health data analytics, though its nonprofit status limits direct equity benefit. The highest-conviction signal is Leidos’ competitive win in full-and-open competition, reinforcing its moat in FAA IT systems. Key risks include the mature phase of Leidos’ base contract (92% outlayed) and Harvard Pilgrim’s contract expiration in December 2024, creating re-compete uncertainty.

2 total filings